Article Information
History
- April 3, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- A Flora1,2,3,
- R Jepsen4,
- EK Kozera2,3,
- JA Woods2,3,
- GD Cains2,3,
- M Radzieta5,6,
- SO Jensen6,
- M Malone5,6 and
- JW Frew1,2,3,4,*
- 1Laboratory of Translational Cutaneous Medicine, Ingham Institute for Applied Medical Research, Sydney, Australia
- 2University of New South Wales, Sydney, Australia
- 3Department of Dermatology, Liverpool Hospital, Sydney, Australia
- 4Holdsworth House Medical Practice, Sydney, Australia
- 5South West Sydney Limb Preservation and Wound Research. Ingham Institute for Applied Medical Research
- 6School of Medicine, Western Sydney University, Sydney, Australia
- ↵*Corresponding Author
Dr John W. Frew, Laboratory of Translational Cutaneous Medicine, Department of Dermatology, Liverpool Hospital, Suite 7, Level 1, 45-47 Goulburn St, Liverpool NSW 2170, Ph: +61 2 87384560, Fax: +61 2 87384639, Email: john.frew{at}unsw.edu.au
Posted April 03, 2023.
Mast cells are upregulated in Hidradenitis Suppurativa Tissue, associated with epithelialized tunnels and normalised by Spleen Tyrosine Kinase Antagonism
